BioRender 图标

Microfluidic device (step emulsification, partial cross-section)

Microfluidic device (step emulsification, partial cross-section) - Editable icon of a zoom in of a partial cross section of a microfluidic device for step emulsification with 3 channels shown in a 3/4 view
[{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d54/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d54/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d53/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d53/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d52/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d52/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d51/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d51/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d50/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d50/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4f/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4f/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4e/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4e/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4d/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4d/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4c/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4c/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4b/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4b/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4a/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4a/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d49/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d49/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d48/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d48/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d47/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d47/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d46/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d46/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d45/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d45/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d44/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d44/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d43/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d43/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d42/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d42/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d41/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d41/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d40/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d40/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3f/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3f/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3e/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3e/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3d/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3d/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3c/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3c/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3b/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3b/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3a/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3a/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d39/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d39/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d38/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d38/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d37/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d37/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d36/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d36/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d35/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d35/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d34/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d34/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d33/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d33/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d32/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d32/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d31/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d31/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d30/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d30/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d2f/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d2f/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d2e/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d2e/64063ecb97c2ea0020512d2d.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍
page dashboard

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
microfluidic,device,step,emulsification,parallelized,microchannel,microparticle,particle,hydrogel,chip,oil,slide,liquid,phase-separation,polymerizable,cells,tissues,cellular,fabricate,polyethylene,glycol,PEG,gelatin,aqueous,two-phase,system,ATPS,droplets,cross-linked,nanovials,cavity,sorting,liquid,slide,chip,oil,spontaneous transformation mechanisms,bubble formation,3/4,three-quarter,3D,three dimensional
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Microfluidic device (step emulsification, partial cross-section) icon JPEG

Microfluidic device (step emulsification, partial cross-section) icon PNG

Microfluidic device (step emulsification, partial cross-section) icon SVG

Microfluidic device (step emulsification, partial cross-section) icon GIF

BioRender 图标常见问题解答

How are scientists using the Microfluidic device (step emulsification, partial cross-section) icon in their work?

BioRender users often use the Microfluidic device (step emulsification, partial cross-section) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Lab and Objects.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Microfluidic device (step emulsification, partial cross-section) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Microfluidic device (step emulsification, partial cross-section) icon customizable in BioRender?

Most icons in BioRender, including the Microfluidic device (step emulsification, partial cross-section) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Microfluidic device (step emulsification, partial cross-section) icon for publication or presentations?

Yes, figures containing the Microfluidic device (step emulsification, partial cross-section) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Microfluidic device (step emulsification, partial cross-section) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Microfluidic device (step emulsification, partial cross-section) icon — especially those focused on Lab and Objects. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Microfluidic device (step emulsification, partial cross-section) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon